Surgery Partners, Inc. (SGRY) Misses Q3 EPS by 6c; reaffirms guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Surgery Partners (SGRY) PT Lowered to $40 at Jefferies
November 13, 2024 4:03 PM ESTJefferies analyst Brian Tanquilut lowered the price target on Surgery Partners (NASDAQ: SGRY) to $40.00 (from $47.00) while maintaining a Buy rating.
The analyst comments "Our takes post-Q3 release/call: 1) some of the stock's weakness is due to rotation out by... More
Surgery Partners (SGRY) PT Lowered to $31 at Barclays
November 13, 2024 9:44 AM ESTBarclays analyst Andrew Mok lowered the price target on Surgery Partners (NASDAQ: SGRY) to $31.00 (from $32.00) while maintaining a Equalweight rating.
The analyst comments "Free Cash Flow: SGRY has delivered about $36 mn free cash flow YTD, representing about 25% of the informal 2024 target... More
